{"entities":{"203":[203,"Auteurs","2020-02-01.pdf","Prevalence et impact des maladies cardiovasculaires dans la COVID-19: Mise au point.","Prevalence and impact of cardiovascular disease on COVID-19:\r\nA review","Yosra Messaoudi","COVID 19, maladies cardiovasculaires, pr\u00e9valence, morbimortalit\u00e9","COVID 19-\r\ncardiovascular diseases,\r\nprevalence, morbidity"],"204":[204,"Auteurs","2020-02-02.pdf","Biomarqueurs cardiaques dans le COVID-19 : Mise au point","Cardiac injury biomarkers in COVID-19: A review","Tarek Ellouze, Amine Bahloul, Selma Charfeddine, Faten Triki, Rania Hammami, Leila Abid, Samir Kammoun","maladies cardiovasculaires, biomarqueurs cardiaques, myocardite, coronavirus, troponines cardiaques, complications thrombotiques, inflammation.","Cardiovascular disease,\r\ncardiac biomarkers,\r\nmyocarditis, coronavirus,\r\ncardiac troponins,\r\nthrombotic complications,\r\ninflammation."],"205":[205,"Auteurs","2020-02-03.pdf","Prise en charge du syndrome coronaire aigu sans sus-d\u00e9calage de ST pendant la pand\u00e9mie de COVID-19","Management of Non-ST Elevation Acute Coronary\r\nSyndrome during the COVID-19 Pandemic.","Amine Bahloul, Tarek Ellouze, Rania Hammami, Selma Charfeddine, Faten Triki, Souad Mallek, Leila Abid, Samir kammoun","Coronavirus 19, COVID19, SARS-CoV2-2, Syndrome coronaire aigu, myocardite, troponine","Coronavirus disease\r\n2019, COVID-19,\r\nSARS-CoV-2, NSTEMI,\r\nAcute coronary\r\nsyndrome, myocarditis,\r\ncardiac troponin"],"206":[206,"Auteurs","2020-02-04.pdf","Doit-on changer notre prise en charge du syndrome coronarien ST+ pendant la pand\u00e9mie COVID-19 ?","Should COVID\u201319 change our way to treat ST elevation\r\nmyocardial infarction patients?","Mohamed Aymen Abdessalem","Covid-19; Syndrome coronaire aigu avec sus d\u00e9calage ST","Covid-19; STEMI"],"207":[207,"Auteurs","2020-02-05.pdf","COVID-19 et Accident Vasculaire C\u00e9r\u00e9bral : Quel lien et quelles particularit\u00e9s diagnostiques et th\u00e9rapeutiques ?","COVID-19 and stroke: which link and which diagnostic and\r\ntherapeutic features?","Nadia Bouattour\r\n, Amine Bahloul\r\n, Nouha Farhat\r\n, Mariem Damak\r\n, Samir Kamoun\r\n, Chokri Mhiri","Accident vasculaire c\u00e9r\u00e9bral ; Accident Vasculaire C\u00e9r\u00e9bral isch\u00e9mique ; Accident Vasculaire C\u00e9r\u00e9bral H\u00e9morragique ; Coronavirus-19 ; COVID-19 ; SARS-CoV2; Thrombolyse ; Thrombectomie","Acute Stroke; Ischemic\r\nStroke; Hemorrhagic\r\nStroke; Coronavirus-19;\r\nCOVID-19; SARS-CoV2; Thrombolysis;\r\nThrombectomy"],"208":[208,"Auteurs","2020-02-06.pdf","Covid-19 et embolie pulmonaire : une association fortuite ou lien de causalit\u00e9 ?","Covid-19 and pulmonary embolism: A fortuitous association\r\nor causal link?","Manel Ben Halima\r\n, Bassem Rekik\r\n, Slim Boudiche\r\n, Fathia Megaieth\r\n, Rim Ben Rejab, Sana Ouali\r\n, Nourredine Larbi\r\n, Mohamed Sami Mourali","Covid-19 \u2013 Thromboses \u2013Embolie pulmonairecoagulopathie- traitement anticoagulant","Covid-19 \u2013 Thrombosis\r\n\u2013 Pulmonaryembolism \u2013\r\nCoagulopathy \u2013\r\nAntithrombotictherapy"],"209":[209,"Auteurs","2020-02-07.pdf","Risque des troubles du rythme ventriculaire li\u00e9 \u00e0 la chloroquine dans le traitement de la Covid-19","Ventricular arrhythmia risk due to Chloroquine in the\r\ntreatment of COVID-19","Aymen El Hraiech\r\n, Imen Ben Ali\r\n, Saeb Ben Saad","Arythmie, Chloroquine, SARS-CoV-2, COVID19, Tunisie.","Ventricular arrhythmia,\r\nChloroquine, SARSCoV-2, COVID-19,\r\nTunisia."],"210":[210,"Auteurs","2020-02-08.pdf","Mort subite et arythmies ventriculaires graves \u00e0 l'\u00e8re de la COVID-19","Sudden cardiac death and severe ventricular arrhythmias in\r\nthe COVID-19 era","Emna Allouche","Covid-19; Mort subite; trouble du rythme cardiaque","Covid-19; Sudden\r\ncardiac death; cardiac\r\narrhythmia"]}}